Below are the most recent publications written about "Osteoarthritis, Knee" by people in Profiles.
-
Uhlrich SD, Mazzoli V, Silder A, Finlay AK, Kogan F, Gold GE, Delp SL, Beaupre GS, Kolesar JA. Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial. Lancet Rheumatol. 2025 Oct; 7(10):e708-e718.
-
Tambiah J, Kennedy S, Swearingen C, McAlindon T, Yazici Y. Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials. Rheumatology (Oxford). 2025 May 01; 64(5):2583-2590.
-
Ayers DC, Zheng H, Yang W, Yousef M. The Chitranjan S. Ranawat Award: Factors That Predict Outcome Five Years Following Total Knee Arthroplasty. J Arthroplasty. 2025 Jul; 40(7S1):S12-S19.
-
Murrietta AJ, Bonano JC, Finlay AK, Huddleston JI, Goodman SB, Maloney WJ, Amanatullah DF. Recommending Surgery Increases Patient Satisfaction With Their Arthroplasty Surgeon. J Arthroplasty. 2025 Aug; 40(8):1967-1971.
-
Yazici Y, Tambiah JRS, Swearingen CJ, Lopez VA, Kennedy S, Fineman MS, Simsek I, Solomon E, Mcalindon TE. A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. Clin Exp Rheumatol. 2025 May; 43(5):847-853.
-
Yazici Y, Tambiah JRS, Swearingen CJ, Britt J, Kennedy S, Fineman MS, Simsek I, Solomon E, McAlindon TE. A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis. Clin Exp Rheumatol. 2025 May; 43(5):854-860.
-
Harkey MS, Driban JB, Todem D, Kuenze C, Mahmoudian A, Meiring R, O'Brien D, Ward S. Evaluating Criteria for Symptoms Suggestive of Early Osteoarthritis Over Two Years Post-Anterior Cruciate Ligament Reconstruction: Data From the New Zealand Anterior Cruciate Ligament Registry. Arthritis Care Res (Hoboken). 2025 Apr; 77(4):475-483.
-
Harkey MS, Driban JB, Baez SE, Genoese FM, Reiche ET, Collins K, Walaszek M, Triplett A, Wilcox CL, Schorfhaar A, Shingles M, Joseph S, Kuenze C. Persistent Early Knee Osteoarthritis Symptoms From 6 to 12 Months After Anterior Cruciate Ligament Reconstruction. J Athl Train. 2024 Sep 01; 59(9):891-897.
-
Parhar D, Dhatt R, Liu SH, Slater A, Liu L, Khan N, Badii M, Masri B, Liu DM. Advances in Interventional Radiology Technology for the Treatment of Knee Osteoarthritis. Orthop Clin North Am. 2024 Oct; 55(4):435-443.
-
Villagran M, Driban JB, Lu B, MacKay JW, McAlindon TE, Harkey MS. Radiomic features of the medial meniscus predicts incident destabilizing meniscal tears: Data from the osteoarthritis initiative. J Orthop Res. 2024 Sep; 42(9):2080-2087.